Rejuvenate Bio
Tracked across 1 events · 6 articles · First seen Jun 08, 2026 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Rejuvenate Bio>>>, a biotechnology company specializing in gene therapies for chronic and age-related diseases, has successfully closed a $6 million financing round. The round was led by VCapital>>> with significant participation from Ceva Santé Animale>>>,…
Impact: Rejuvenate Bio successfully closed a $6 million financing round and entered into a strategic R&D collaboration with Ceva Santé Animale>>>, which will support the advancement of its gene therapy platform and pipeline for chronic and age-related diseases in companion animals and potentially humans.
Jun 08, 2026 · 6 articles
100
Rejuvenate Bio closed financing roundRejuvenate Bio closes $6M financing
95
Rejuvenate Bio entered collaboration Ceva Santé AnimaleRejuvenate Bio closes $6M financing
70
VCapital led financing round Rejuvenate BioRejuvenate Bio closes $6M financing
NEWSDESK
Track Rejuvenate Bio live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard